The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia.

Back

ESC Professional Premium Access

The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia.

Session: Platelets and thrombosis: novel experimental aspects

Topic: Cardiac Biology and Physiology

Speaker: Mr T. Pirker (Christchurch, NZ)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Thomas Pirker

Christchurch (New Zealand)

0 follower

4 more presentations in this session

Sphingosine-1-phosphate reduces arterial thrombosis via enhanced endothelial thrombomodulin expression by S1PR1 signaling

Speaker: Doctor M. Benkhoff (Duesseldorf, DE)

Single-cell mass cytometry analysis unveils prothrombotic expression and heterogeneity in essential thrombocythemia

Speaker: Doctor S. Kuehne (Augsburg, DE)

Thrombin generation, fibrin clot permeation and lysis in patients with severe mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair: mitral fibrin study.

Speaker: Doctor A. Siniarski (Krakow, PL)

Direct IL-6 inhibition prevents arterial thrombosis by reducing collagen-mediated platelets activation

Speaker: Doctor S. Ministrini (Zurich, CH)

Access the full session

Platelets and thrombosis: novel experimental aspects

Speakers: Mr T. Pirker, Doctor M. Benkhoff, Doctor S. Kuehne, Doctor A. Siniarski, Doctor S. Ministrini

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources